


The Fund aims to achieve both capital growth and an attractive level of income.
| Name | % Net Assets | 
|---|---|
| Aberdeen Global II - Sterling Aggregateb | 17.5% | 
| Sterling Bond Fund Z-1B | 15.7% | 
| Dated Sterling Aggregate B | 4.6% | 
| Aberdeen Global II - Dated Sterling AggregateB | 3.1% | 
| HSBC | 2.8% | 
| British American Tobacco | 2.6% | 
| Royal Dutch Shell 'B' | 2.1% | 
| GlaxoSmithKline | 2.1% | 
| Centrica | 2.0% | 
| ASTRAZENECA | 2.0% | 
| Key | % Net Assets | 
|---|---|
| 17.5% | |
| 15.7% | |
| 4.6% | |
| 3.1% | |
| 59.1% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 274.28p | 
| Currency | GBP | 
| Change | 0.29p | 
| % | 0.11% | 
| YTD change | 17.02p | 
| YTD % | 6.62% | 
| Fund Inception | 17/11/2006 | 
|---|---|
| Fund Manager | Aberdeen Multi-Asset | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.25% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research